A single blood draw measuring a protein fragment called p-tau217 can now estimate when Alzheimer’s symptoms will appear in a ...

Skyfall AI, from the team behind Microsoft's $160 million Maluuba acquisition, will buy a SaaS company and let AI run it as ...

Obicetrapib, a cholesterol-lowering drug already in Phase 3 cardiovascular trials, significantly reduced a validated ...

OpenAI released GPT-5.6 this week as a three-tier model family split into Sol, Terra, and Luna, each targeting a different ...

Antiamyloid drugs clear amyloid plaques and modestly slow cognitive decline in patients with Alzheimer’s disease, but whether the therapies produce meaningful clinical benefit is up for debate.

Tissue engineers are finding ways to grow living organs and tissues from cells, with the aim of replacing diseased and ...

A new study has found that people who achieved success through hardship are actually more likely to oppose measures that would spare others from the same strugg ...

The startup has a new commercial trash bin that analyzes food scraps as they’re thrown inside. Over the last year, the design team at Mill has logged hundreds of hours in commercial kitchens studying ...

Image courtesy by QUE.com For decades, the search for room-temperature superconductors has been one of physics' most ...

Gold is not the only hedge against inflation, suggesting that a link should exist between gold’s sensitivity to inflation and ...

Walk into any private equity boardroom in the final 18 months of a hold period, and you can feel the temperature shift before ...

Nuovi sviluppi sul delitto di Garlasco: durante Morning News emergono le dichiarazioni dell'avvocato di Stasi su un collega di Chiara Poggi e sulle nuove indagini che coinvolgono Sempio.